Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|April 26, 1994
L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitorJ P Vacca, B D Dorsey, W A Schleif, et al.
Journal of Medicinal Chemistry|October 14, 1994
L-735,524: the design of a potent and orally bioavailable HIV protease inhibitorB D Dorsey, R B Levin, S L McDaniel, et al.
Drug Design and Discovery|January 1, 1993
HIV-1 protease inhibitors: synthesis and biological evaluation of glycopeptidemimeticsA K Ghosh, S P McKee, W M Sanders, et al.
AIDS Research and Human Retroviruses|November 1, 1990
Yeast-expressed p55 precursor core protein of human immunodeficiency virus type 1 does not elicit protective immunity in chimpanzeesE A Emini, W A Schleif, J C Quintero, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1991
Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activityM E Goldman, J H Nunberg, J A O'Brien, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1992
L-696,229 specifically inhibits human immunodeficiency virus type 1 reverse transcriptase and possesses antiviral activity in vitroM E Goldman, J A O'Brien, T L Ruffing, et al.
Orthodontics & Craniofacial Research|April 14, 2015
3D superimposition and understanding temporomandibular joint arthritisL H S Cevidanes, L R Gomes, B T Jung, et al.
Molecular & Cellular Proteomics : MCP|March 27, 2025
Bioinformatics-Guided Identification and Quantification of Biomarkers of Crotalus atrox Envenoming and Its Neutralization by AntivenomAuwal A Bala, Anas Bedraoui, Salim El Mejjad, et al.
Pageof 13